Document

DailyMed Label: Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser

Title
DailyMed Label: Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser
Date
2024
Document type
DailyMed Prescription
Name
Sodium Sulfacetamide 10 % and Sulfur 5 % Cleanser
Generic name
Sodium Sulfacetamide and Sulfur
Manufacturer
Oncor Pharmaceuticals
Product information
NDC: 83720-537
Product information
NDC: 83720-537
Description
Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl)sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is: Each gram of sodium sulfacetamide 10% and sulfur 5% cleanser contains 100 mg of sodium sulfacetamide and 50 mg of sulfur in a cleanser containing ammonium Aloe Vera leaf Extract, Butylated Hydroxytoluene, Cetyl Alcohol, Citric Acid, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium Laureth Sulfate, Sodium Thiosulfate, Stearyl alcohol, Triacetin, Xanthan Gum. Sructure
Indications
INDICATIONS:  Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Dosage
DOSAGE AND ADMINISTRATION:  Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and liberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or using less often.
Contraindications
CONTRAINDICATIONS:  Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is not to be used by patients with kidney disease.
Precautions
GENERAL: If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility. INFORMATION FOR PATIENTS:  Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician. CARSINOGENESIS, MUTAGENESIS AND IMPAIRMENT OF FERTILITY:  Long-term studies in animals have not been performed to evaluate carcinogenic potential. PREGNANCY:  Category C. Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% & Sulfur 5% Cleanser. It is also not known whether Sodium Sulfacetamide 10% & Sulfur 5% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser should be given to a pregnant woman only if clearly needed.
Adverse reactions
How supplied
HOW SUPPLIED:  Sodium Sulfacetamide 10% & Sulfur 5% | Cleanser is available in a 6 oz (170 g) bottle NDC 83720-537-06 and a 12 oz (340 g) bottle NDC 83720-537-12 Storage: Store at 20 to 25°C (68 to 77°F). See USP Controlled Room Temperature. Protect from freezing. You may report side effects by calling Oncor Pharmaceuticals (9 a.m. to 5 p.m. EST), at 1-443-876-7900 or FDA at 1-800-FDA-1088.
Clinical pharmacology
CLINICAL PHARMACOLOGY:  The most widely accepted mechanism of action of sulfonamides is the Woods-fields theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 1 hours. The exact mode of action of sulfur in the treatment of acne is unknown but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.
Package label
ONCOR PHARMACEUTICALS NDC 83720-537-06 Rx Only Sodium Sulfacetamide & Sulfur  Sodium Sulfacetamide 10% Sulfur 5% 10%/5% Cleanser For External Use Only NET WT.6 OZ. (170.3 g) label

2 organizations

1 product

Organization
SOHM, Inc